Favorable Response to Chemotherapy in a Patient of Urachal Adenocarcinoma with Peritoneal Metastasis

Authors

  • Danielle Zimmerman University of Kansas Medical Center
  • Mehmood Hashimi
  • Rachel Cherian
  • Peter Van Veldhuizen

DOI:

https://doi.org/10.17161/kjm.v8i3.11531

Keywords:

urachal adenocarcinoma, carcinoembryonic antigen, flurorouracil, FOLFOX protocol

Metrics

File downloads
402
Jan 2016Jul 2016Jan 2017Jul 2017Jan 2018Jul 2018Jan 2019Jul 2019Jan 2020Jul 2020Jan 2021Jul 2021Jan 2022Jul 2022Jan 2023Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 20269
|

Downloads

Published

2015-08-05

Issue

Vol. 8 No. 3 (2015)

Section

Case Reports

License

All articles in the Kansas Journal of Medicine are licensed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND 4.0). 

 

How to Cite

Zimmerman, D., Hashimi, M., Cherian, R., & Van Veldhuizen, P. (2015). Favorable Response to Chemotherapy in a Patient of Urachal Adenocarcinoma with Peritoneal Metastasis. Kansas Journal of Medicine, 8(3), 118-121. https://doi.org/10.17161/kjm.v8i3.11531